Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway
Open Access
- 14 September 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 9930
Abstract
Feline infectious peritonitis (FIP), a serious infectious disease in cats, has become a challenging problem for pet owners and the industry due to the lack of effective vaccinations and medications for prevention and treatment. Currently, most natural compounds have been proven to have good antiviral activity. Hence, it is essential to develop efficacious novel natural compounds that inhibit FIPV infection. Our study aimed to screen compounds with in vitro anti-FIPV effects from nine natural compounds that have been proven to have antiviral activity and preliminarily investigate their mechanisms of action. In this study, the CCK-8 method was used to determine the maximum noncytotoxic concentration (MNTC), 50% cytotoxic concentration (CC50), and 50% effective concentration (EC50) of natural compounds on CRFK cells and the maximum inhibition ratio (MIR) of the compounds inhibit FIPV. The effect of natural compounds on FIPV-induced apoptosis was detected via Annexin V-FITC/PI assay. Network pharmacology (NP), molecular docking (MD), and 4D label-free quantitative (4D-LFQ) proteomic techniques were used in the joint analysis the mechanism of action of the screened natural compounds against FIPV infection. Finally, Western blotting was used to validate the analysis results. Among the nine natural compounds, baicalin had good antiviral effects, with an MIR > 50% and an SI > 3. Baicalin inhibited FIPV-induced apoptosis. NP and MD analyses showed that AKT1 was the best target of baicalin for inhibiting FIPV infection. 4D-LFQ proteomics analysis showed that baicalin might inhibit FIPV infection by modulating the PI3K-AKT pathway and the apoptosis pathway. The WB results showed that baicalin promoted the expression of EGFR, PI3K, and Bcl-2 and inhibited the expression of cleaved caspase 9 and Bax. This study found that baicalin regulated the PI3K-AKT pathway and the apoptosis pathway in vitro and inhibited FIPV-induced apoptosis, thus exerting anti-FIPV effects.Keywords
Funding Information
- Innovation Ability Promotion Project of Sci-Tech SMEs of Shandong Province (2022TSGC2270, 2023XTTG01, 202204051001021, 2022YFD1800603)
- Agricultural Major Technology Synergistic Extension Project of Shanxi Province (2022TSGC2270, 2023XTTG01, 202204051001021, 2022YFD1800603)
- Science and technology innovation talent team of Shanxi Province (2022TSGC2270, 2023XTTG01, 202204051001021, 2022YFD1800603)
- National Key Research and Development Program of China (2022TSGC2270, 2023XTTG01, 202204051001021, 2022YFD1800603)
This publication has 55 references indexed in Scilit:
- Baicalin inhibits influenza A (H1N1)‐induced pyroptosis of lung alveolar epithelial cells via caspase‐3/GSDME pathwayJournal of Medical Virology, 2023
- Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studiesPhytotherapy Research, 2020
- The role of PI3K/AKT/FOXO signaling in psoriasisArchives of Dermatological Research, 2018
- Corin protects H2O2-induced apoptosis through PI3K/AKT and NF-κB pathway in cardiomyocytesBiomedicine & Pharmacotherapy, 2018
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Apoptosis transcriptional mechanism of feline infectious peritonitis virus infected cellsApoptosis, 2015
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networksBioSystems, 2015
- In vitroAnti‐Herpes Simplex Virus Activity of 1,2,4,6‐Tetra‐O‐galloyl‐β‐d‐glucose fromPhyllanthus emblicaL. (Euphorbiaceae)Phytotherapy Research, 2011
- In vitro anti HSV‐1 and HSV‐2 activity of Tanacetum vulgare extracts and isolated compounds: An approach to their mechanisms of actionPhytotherapy Research, 2010
- Identification of natural compounds with antiviral activities against SARS-associated coronavirusAntiviral Research, 2005